{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+%28Placebo%29+applied+BID&page=4", "query": { "intervention": "Vehicle (Placebo) applied BID", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 76, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+%28Placebo%29+applied+BID&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+%28Placebo%29+applied+BID&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T09:57:32.590Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03287791", "title": "A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "Generic Azelaic Acid Foam", "type": "DRUG" }, { "name": "Finacea® (Azelaic Acid) Foam", "type": "DRUG" }, { "name": "Vehicle Foam", "type": "DRUG" }, { "name": "Cleanser", "type": "OTHER" }, { "name": "Sunscreen", "type": "OTHER" }, { "name": "Towel", "type": "OTHER" }, { "name": "Moisturizing Lotion", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 924, "start_date": "2016-07-19", "completion_date": "2017-06-22", "has_results": true, "last_update_posted_date": "2019-07-31", "last_synced_at": "2026-10-08T09:57:32.590Z", "location_count": 26, "location_summary": "Encino, California • La Mesa, California • Brandon, Florida + 20 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03287791" }, { "nct_id": "NCT00119158", "title": "Combination Therapy for Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Combination of pimecrolimus and fluticasone", "type": "DRUG" }, { "name": "pimecrolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "2 Years to 65 Years" }, "enrollment_count": 90, "start_date": "2004-10", "completion_date": "2005-06", "has_results": true, "last_update_posted_date": "2010-07-27", "last_synced_at": "2026-10-08T09:57:32.590Z", "location_count": 3, "location_summary": "Denver, Colorado • Chicago, Illinois • Houston, Texas", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00119158" }, { "nct_id": "NCT05078827", "title": "Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Actinic Keratoses" ], "interventions": [ { "name": "Test Product (A): Fluorouracil Cream, 5% topical cream", "type": "DRUG" }, { "name": "Reference Product (B): Fluorouracil 5% Topical Cream of Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.", "type": "DRUG" }, { "name": "Placebo Product (C): Test vehicle cream for fluorouracil 5% of Encube Ethicals Pvt. Ltd., India", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Encube Ethicals Pvt. Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 458, "start_date": "2022-03-01", "completion_date": "2022-12-01", "has_results": false, "last_update_posted_date": "2023-03-14", "last_synced_at": "2026-10-08T09:57:32.590Z", "location_count": 7, "location_summary": "Bakersfield, California • Cerritos, California • Lauderdale Lakes, Florida + 3 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Lauderdale Lakes", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05078827" }, { "nct_id": "NCT02828111", "title": "Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Basal Cell Carcinomas" ], "interventions": [ { "name": "Patidegib", "type": "DRUG" }, { "name": "Vehicle gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PellePharm, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 36, "start_date": "2016-11-11", "completion_date": "2017-11-09", "has_results": true, "last_update_posted_date": "2019-01-08", "last_synced_at": "2026-10-08T09:57:32.590Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02828111" }, { "nct_id": "NCT02186665", "title": "Plaque Psoriasis Study in Pediatric Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "calcitriol ointment", "type": "DRUG" }, { "name": "placebo comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "2 Years to 12 Years" }, "enrollment_count": 19, "start_date": "2014-07", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-10-08T09:57:32.590Z", "location_count": 12, "location_summary": "Beverly Hills, California • Sacramento, California • Louisville, Kentucky + 9 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Jackson", "state": "Mississippi" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02186665" }, { "nct_id": "NCT03028363", "title": "A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Olumacostat Glasaretil Gel, 5.0%", "type": "DRUG" }, { "name": "Olumacostat Glasaretil Gel, Vehicle", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Dermira, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 759, "start_date": "2016-12-27", "completion_date": "2017-11-28", "has_results": true, "last_update_posted_date": "2021-07-20", "last_synced_at": "2026-10-08T09:57:32.590Z", "location_count": 38, "location_summary": "Phoenix, Arizona • Anaheim, California • Los Angeles, California + 30 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03028363" }, { "nct_id": "NCT01740934", "title": "A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "Anatabloc Cream", "type": "OTHER" }, { "name": "Placebo Cream", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Rock Creek Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "25 Years to 70 Years" }, "enrollment_count": 117, "start_date": "2012-11", "completion_date": "2013-08", "has_results": false, "last_update_posted_date": "2015-11-02", "last_synced_at": "2026-10-08T09:57:32.590Z", "location_count": 3, "location_summary": "Bradenton, Florida • New Orleans, Louisiana • New York, New York", "locations": [ { "city": "Bradenton", "state": "Florida" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01740934" }, { "nct_id": "NCT03903822", "title": "Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "PF-06700841", "type": "DRUG" }, { "name": "Vehicle (Placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 292, "start_date": "2019-05-13", "completion_date": "2020-05-07", "has_results": true, "last_update_posted_date": "2021-03-29", "last_synced_at": "2026-10-08T09:57:32.590Z", "location_count": 36, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Encinitas, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03903822" }, { "nct_id": "NCT02068352", "title": "A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "OPA-15406", "type": "DRUG" }, { "name": "Vehicle ointment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "10 Years to 70 Years" }, "enrollment_count": 121, "start_date": "2014-06-20", "completion_date": "2015-02-03", "has_results": true, "last_update_posted_date": "2021-11-23", "last_synced_at": "2026-10-08T09:57:32.590Z", "location_count": 20, "location_summary": "Los Angeles, California • San Diego, California • Denver, Colorado + 17 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Orange Park", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02068352" }, { "nct_id": "NCT06050122", "title": "Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Gorlin Syndrome" ], "interventions": [ { "name": "Patidegib Topical Gel", "type": "DRUG" }, { "name": "Patidegib Topical Gel with no active patidegib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 113, "start_date": "2024-03-17", "completion_date": "2026-09-14", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-08T09:57:32.590Z", "location_count": 24, "location_summary": "Rogers, Arkansas • Fremont, California • Los Angeles, California + 21 more", "locations": [ { "city": "Rogers", "state": "Arkansas" }, { "city": "Fremont", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06050122" } ] }